EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Peroxisome Dysfunction and Steatotic Liver Disease

Navia Vinoy, Gary Huang iD, Daniel F Wallace, V Nathan Subramaniam iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26178303 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Navia Vinoy und 3 weiteren Autor:innen. Beteiligte Einrichtung: Hepatogenomics Research Group, Queensland University of Technology (QUT), Brisbane, QLD 4059, Australia. Hauptthemen laut MEDLINE: Peroxisomes, Peroxisomal Disorders, Fatty Liver. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 178 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Centre for Genomics and Personalised Health, The Queensland University of Technology (QUT).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Peroxisomes are cellular organelles involved in multiple metabolic processes, including lipid oxidation, lipid synthesis, and the metabolism of reactive oxygen species. Peroxisomal disorders arise from defects in peroxisomal biogenesis or peroxisomal enzymes. Patients with severe peroxisomal disorders often present with a range of distinctive physical features and congenital malformations, such as neuronal migration defects, renal cysts, and bony stippling in the patellae and long bones. Liver disease has also been reported in some patients with peroxisomal biogenesis disorders, although the exact molecular mechanisms underlying its development remain unclear. Metabolic dysfunction-associated steatotic liver disease (MASLD) is now recognised as one of the most prevalent causes of chronic liver disease globally, due to its widespread incidence and potential for serious complications. This review aims to highlight the possible involvement of peroxisomal defects in the pathogenesis of MASLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PeroxisomesPeroxisomal DisordersFatty LiverHumansAnimalsReactive Oxygen Species

Stichwörter der Autor:innen

beta-oxidationfatty acid oxidationfatty acid synthesisliver diseasemetabolic dysfunction-associated steatotic liver diseaseperoxisomes

Substanzen

Reactive Oxygen Species

Autor:innen und Institutionen

  • Hepatogenomics Research Group, Queensland University of Technology (QUT), Brisbane, QLD 4059, Australia.
  • Centre for Genomics and Personalised Health, School of Biomedical Sciences, Queensland University of Technology (QUT), Brisbane, QLD 4059, Australia.
  • Metallogenomics Laboratory, Queensland University of Technology (QUT), Brisbane, QLD 4059, Australia.

ORCID-Profile: Gary Huang, V Nathan Subramaniam

Förderung

  • Centre for Genomics and Personalised Health, The Queensland University of Technology (QUT)

Zitieren

APA

Vinoy, N., Huang, G., Wallace, D. F., & Subramaniam, V. N. (2025). Peroxisome Dysfunction and Steatotic Liver Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26178303

Vancouver

Vinoy N, Huang G, Wallace DF, Subramaniam VN. Peroxisome Dysfunction and Steatotic Liver Disease. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26178303

BibTeX
@article{Vinoy2025,
  author = {Vinoy, Navia and Huang, Gary and Wallace, Daniel F and Subramaniam, V Nathan},
  title = {Peroxisome Dysfunction and Steatotic Liver Disease},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26178303}
}
Kostenlos starten →